Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.

Fauchier L, Greenlaw N, Ferrari R, Ford I, Fox KM, Tardif JC, Tendera M, Steg PG; CLARIFY Investigators.

PLoS One. 2015 Apr 27;10(4):e0125164. doi: 10.1371/journal.pone.0125164. eCollection 2015.

2.

Ivabradine in stable coronary artery disease without clinical heart failure.

Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R; SIGNIFY Investigators.

N Engl J Med. 2014 Sep 18;371(12):1091-9. doi: 10.1056/NEJMoa1406430. Epub 2014 Aug 31.

3.

Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients.

Kalra PR, García-Moll X, Zamorano J, Kalra PA, Fox KM, Ford I, Ferrari R, Tardif JC, Tendera M, Greenlaw N, Steg PG; CLARIFY Investigators.

PLoS One. 2014 Jul 22;9(7):e102335. doi: 10.1371/journal.pone.0102335. eCollection 2014.

4.

Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.

Steg PG, Ferrari R, Ford I, Greenlaw N, Tardif JC, Tendera M, Abergel H, Fox KM; CLARIFY Investigators.

PLoS One. 2012;7(5):e36284. doi: 10.1371/journal.pone.0036284. Epub 2012 May 3.

5.

Influence of gender on long-term prognosis of patients with chronic heart failure seen in heart failure clinics.

Jiménez-Navarro MF, Ramirez-Marrero MA, Anguita-Sánchez M, Castillo JC; BADAPIC Investigators.

Clin Cardiol. 2010 Mar;33(3):E13-8. doi: 10.1002/clc.20476.

6.

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators.

Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8. Epub 2008 Aug 29.

PMID:
18757088
8.

[Prognostic value of troponin T in hospitalized patients with angina or non-ST-segment elevation myocardial infarction].

Roldán Torres I, Baello Monge P, Sevilla Toral B, Salvador Sanz A, Salim Martínez M, Peláez González A, Mora Llabata V, Martínez Diago V, Morales Suárez-Varela M, Martínez-Triguero ML, Molina Andreu E.

Rev Esp Cardiol. 2003 Jan;56(1):35-42. Spanish.

Supplemental Content

Loading ...
Support Center